| Literature DB >> 35739133 |
Dieter Häussinger1, Radha K Dhiman2, Vicente Felipo3, Boris Görg4, Rajiv Jalan5,6, Gerald Kircheis7, Manuela Merli8, Sara Montagnese9, Manuel Romero-Gomez10, Alfons Schnitzler11, Simon D Taylor-Robinson12, Hendrik Vilstrup13.
Abstract
Hepatic encephalopathy (HE) is a prognostically relevant neuropsychiatric syndrome that occurs in the course of acute or chronic liver disease. Besides ascites and variceal bleeding, it is the most serious complication of decompensated liver cirrhosis. Ammonia and inflammation are major triggers for the appearance of HE, which in patients with liver cirrhosis involves pathophysiologically low-grade cerebral oedema with oxidative/nitrosative stress, inflammation and disturbances of oscillatory networks in the brain. Severity classification and diagnostic approaches regarding mild forms of HE are still a matter of debate. Current medical treatment predominantly involves lactulose and rifaximin following rigorous treatment of so-called known HE precipitating factors. New treatments based on an improved pathophysiological understanding are emerging.Entities:
Mesh:
Year: 2022 PMID: 35739133 DOI: 10.1038/s41572-022-00366-6
Source DB: PubMed Journal: Nat Rev Dis Primers ISSN: 2056-676X Impact factor: 65.038